Talking Medicines

Glasgow, United Kingdom

Talking Medicines gives Pharma and agencies the intelligence to predict and prove HCP messaging impact, closing the $23Bn blind spot.

May 2026

Convertible Note

Artificial Intelligence (AI)Business Intelligence Data Visualization Health Care Machine Learning

Top Investors

Scottish EnterpriseSIS VenturesTernRob DobsonMark Bamforth

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Talking Medicines

Who are Talking Medicines's investors?

Talking Medicines's investors include Scottish Enterprise, SIS Ventures, Tern, Rob Dobson, Mark Bamforth.

Where is Talking Medicines headquartered?

Talking Medicines is headquartered in Glasgow, United Kingdom.

What does Talking Medicines do?

Talking Medicines gives Pharma and agencies the intelligence to predict and prove HCP messaging impact, closing the $23Bn blind spot.

What stage is Talking Medicines at?

Talking Medicines is at the Convertible Note stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 26, 2026.

MLA

"Talking Medicines — Funding & Investors." VCBacked, May 26, 2026, https://www.vcbacked.co/company/talking-medicines. Accessed June 3, 2026.

APA

VCBacked. (2026). Talking Medicines — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/talking-medicines

Wikipedia (cite web)

{{cite web |title=Talking Medicines — Funding & Investors |url=https://www.vcbacked.co/company/talking-medicines |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 26, 2026.

Similar Companies in Artificial Intelligence (AI)